Management of Atrial Fibrillation
Related Experiment Video
Updated: Apr 29, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Payman Zamani1, Ralph J Verdino2
1Division of Cardiovascular Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
Insights
Atrial fibrillation, a common heart rhythm disorder, is increasing with age. Management includes medications for rate or rhythm control and anticoagulation to prevent stroke.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation is the most common cardiac arrhythmia, with increasing incidence in aging populations.
- Associated conditions include hypertension, heart failure, and valvular heart disease.
- Patients may be asymptomatic or present with palpitations, fatigue, or reduced exercise tolerance.
Purpose of the Study:
- To review current management options for atrial fibrillation.
- To discuss pharmacologic and non-pharmacologic treatment strategies.
- To highlight stroke risk reduction in atrial fibrillation patients.
Main Methods:
- Review of existing literature on atrial fibrillation management.
- Analysis of pharmacologic treatments including rate and rhythm control agents.
- Evaluation of anticoagulation therapies and catheter ablation.
Main Results:
- Rate control options include digoxin, beta-blockers, and calcium channel blockers.
- Rhythm control involves sodium and potassium channel blockers or catheter ablation.
- Warfarin is a primary anticoagulation choice, with newer agents offering alternatives.
- Catheter ablation success varies based on atrial fibrillation duration and follow-up.
Conclusions:
- Effective management of atrial fibrillation involves addressing the arrhythmia and associated risks.
- Pharmacologic and interventional options provide tailored treatment strategies.
- Stroke prevention through anticoagulation is a critical component of atrial fibrillation care.
Abstract:
Atrial fibrillation remains the most prevalent cardiac arrhythmia, and its incidence is increasing as the population ages. Common conditions associated with an increased incidence include advanced age, hypertension, heart failure, and valvular heart disease. Patients with atrial fibrillation may complain of palpitations, fatigue, and decreased exercise tolerance or may be completely asymptomatic. Options for treating patients who experience atrial fibrillation include rate-controlling drugs such as digoxin, β-blockers, and calcium channel blockers or a rhythm-controlling strategy with agents such as sodium channel blockers and potassium channel blockers. Atrial fibrillation increases the risk of stroke due to atrial thrombus formation and embolization. Anticoagulation with the vitamin K antagonist, warfarin, remains the most widely prescribed treatment option to decrease stroke risk. Several other antithrombotic agents have recently become available and offer excellent alternatives to warfarin. Catheter ablation can be undertaken as a nonpharmacologic rhythm control option with varying degrees of success depending on duration of atrial fibrillation and follow-up time from the procedure. This review article further describes the management options for patients presenting with atrial fibrillation.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mitral Regurgitation III: Medical Management
Dysrhythmias VII: Nursing Management of Dysrhythmias

